PDF VI.2 Elements for a Public Summary VI.2.1 ... - Lægemiddelstyrelsen

Share "PDF VI.2 Elements for a Public Summary VI.2.1 ... - Lægemiddelstyrelsen"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "PDF VI.2 Elements for a Public Summary VI.2.1 ... - Lægemiddelstyrelsen"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 5 páginas )

Texto

Referências

Descarregar agora ( PDF - 5 páginas - 16.68 KB )

Documentos relacionados

VI.2 Elements for a Public Summary

Risk What is known Including reason why it is considered a potential risk Risk for the heart and blood vessels in patients with type 2 diabetes There have been patients with heart

Documentos relacionados

VI.2 Elements for a Public Summary

,with the World Health Organisation (WHO) estimating that depression affects 350 million people with the burden 50% higher for females than males.

PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen

VI.2 Elements for a Public Summary

Bendamustine is used alone (monotherapy) or in combination with other medicines for the treatment of patients with

Guidance on format of the RMP in the EU in integrated format

VI.2 Elements for a public summary